• Patent must claim drug’s “active ingredient” as invention to qualify for listing in FDA Orange Book.
  • Excess policy didn’t cover defense costs (although primary policy did).
  • Lack of control by vendor over merchants’ use of point of sale “builder” system whose use would infringe patent doomed vicarious infringement claim
  • Discrete features of boot design lacked distinctiveness necessary for trademark.
  • Even a little harm from discriminatory change in work suffices under Title VII.
  • Delay in bringing suit for trademark infringement until after limitations would have expired under state-law analog to Lanham